← Back
$ZNTL All transactions

Zentalis Pharmaceuticals, Inc.

▼ SELL

$ Value

$10.0M

Shares

7,500,000

Price

$1

Filed

Dec 15

Insider

Name

Matrix Capital Management Company, LP

Title

CIK

0001410830

Roles

10% Owner

Transaction Details

Transaction Date

2025-12-15

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

6,459,973

Footnotes

The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager. | The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Filing Info

Accession No.

0000902664-25-005288

Form Type

4

Issuer CIK

0001725160

Matrix Capital Management Company, LP's History

Date Ticker Type Value
2025-12-15 ZNTL $10.0M

Other Insiders at ZNTL (90d)

No other insider activity at this issuer in the last 90 days.